Scotland Faces Shortage of Strong Co-Codamol Until Summer
The shortage affects the 30/500mg formulation of the painkiller and stems from delays in India, where the government has postponed authorisation to export key ingredients needed for production.
Officials said alternative treatments will be offered to patients affected by the disruption, though some health boards have cautioned that no substitute medicine can fully meet the expected demand.
Patients relying on the drug have reported being told it will not be available until June. One such patient, Jocelin Harrison, received guidance from NHS Lanarkshire to reduce her dosage by one tablet per week to “avoid side effects of stopping suddenly.”
Harrison has taken co-codamol for over 30 years to manage pain from five spinal surgeries. She expressed concern about the limited guidance she has received: "the only advice I've been given so far was to reduce the tablets and try to manage my withdrawal symptoms. I was not offered any other advice or possible replacement pain killers and it's a great worry for me and other chronic pain sufferers throughout Scotland and the UK."
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
